Ajanta Pharma has informed that a meeting of the Board of Directors of the Company will be held on April 30, 2013, to consider and approve the Audited Financial Results for the year ended March 31, 2013 and recommending dividend, if any, on equity shares of the Company for the financial year 2012-13.
The above information is a part of company’s filings submitted to BSE.